NL-OMON34283已完成不适用
Study of the Safety, Tolerability and Pharmacokinetics of LY2623091 after Single Oral Dosing in Healthy Subjects - LY2623091 SAD study
Chorus LRL (Division of Eli Lilly)0 个研究点目标入组 18 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Healthy men and women ((postmenopausal/sterilized)
- •- 18 - 65 years of age, inclusive;
- •- BMI < 32.5 kg/m2;
- •- Non smoking or smoking lesss than 10 cigarettes/day
排除标准
- •Suffering from: hepatitis B, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.
研究者
相似试验
已完成
不适用
Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium Clearance after Multiple Oral Dosing of LY2623091 in Healthy VolunteersKidney failure10038430chronic kidney diseaseNL-OMON36630Eli Lilly32
已完成
不适用
Study of Safety, Tolerability, and Pharmacokinetics of BG00010 (Neublastin) Intravenous and Subcutaneous Single Ascending Doses in Healthy Volunteers, and Subcutaneous Multiple Ascending Doses in Subjects with Painful Lumbar Radiculopathylow back painPainful Lumbar Radiculopathy10041543NL-OMON40320Biogen Idec78
进行中（未招募）
1 期
Pediatric PK Study (POS IV and PFS)Prophylaxis of invasive fungal infections in immunocompromised pediatric subjects with neutropenia or expected neutropenia.EUCTR2014-002807-10-CZMerck Sharp & Dohme Corp.84
进行中（未招募）
1 期
Pediatric PK Study (POS IV and PFS)EUCTR2014-002807-10-DEMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.118
进行中（未招募）
1 期
Pediatric PK Study (POS IV and PFS)Prophylaxis of invasive fungal infections in immunocompromised pediatric subjects with neutropenia or expected neutropenia.MedDRA version: 18.0 Level: HLGT Classification code 10017528 Term: Fungal infectious disorders System Organ Class: 10021881 - Infections and infestationsEUCTR2014-002807-10-NOMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.118